12.4
Lexaria Bioscience Corp.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
6.98
FY23:
2.15
FY24:
7.90
FY25:
3.47
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.82
FY22:
0.86
FY23:
0.93
FY24:
0.97
FY25:
0.71
Total assets
Change from FY21 to FY25
millions USD
FY21:
13.3
FY22:
7.83
FY23:
3.08
FY24:
8.87
FY25:
4.18
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.15
FY22:
0.19
FY23:
0.27
FY24:
1.10
FY25:
1.49
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.05
FY22:
0.01
FY23:
0.14
FY24:
0.11
FY25:
0.08
(positive)
Change from FY21 to FY25
millions USD
FY21:
13.3
FY22:
7.95
FY23:
3.04
FY24:
8.04
FY25:
2.99
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
13.5
FY22:
8.15
FY23:
3.45
FY24:
9.25
FY25:
4.56
All amounts in millions USD